C12N 2760/18823
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2760/18823 (Virus like particles [vlp]) appears on 6 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 11
- Assignees
- 10
- Inventors
- 27
- Latest grant
- 31 Aug 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 1 | 3 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 2 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
By publication year.
Recent patents
- Infectious disease vaccine using non-infectious paramyxovirus particle31 Aug 2021US 11,103,574 B2ID Pharma Co., Ltd.
- Virus envelope vector for gene transfer28 Sep 2010US 7,803,621 B2AnGes MG, Inc.
- Virus envelope vector for gene transfer9 Oct 2007US 7,279,333 B2AnGes MG, Inc.
- Envelope gene-deficient Paramyxovirus vector5 Jun 2007US 7,226,786 B2DNAVEC Research Inc.
- Virus envelope vector for gene transfer5 Jul 2005US 6,913,923 B2AnGes MG, Inc.
- Infectious disease vaccine using non-infectious paramyxovirus particle21 May 2020US 2020/0155669 A1ID Pharma Co., Ltd.
- Method for Producing Induced Pluripotent Stem Cells20 Oct 2016US 2016/0304840 A1New England Biolabs, Inc.
- Virus-like particle for use in immunoassay, blocking agent for use in the immunoassay, and kit comprising the virus-like particle and the blocking agent14 Jul 2016US 2016/0202251 A1Beacle Inc.
- Novel protein expression system1 Jul 2010US 2010/0167341 A1DNAVEC Corporation
- Paramyxovirus-derived RNP11 Jan 2007US 2007/0009949 A1
Most cited
By later US patents
- Genetically-engineered alphaviruses, flaviviruses, and bunyaviruses with modified envelope transmembrane glycoproteins and altered host-range phenotype10US 6,589,533 B1Research Development Foundation · 2003
- Virus envelope vector for gene transfer5US 6,913,923 B2AnGes MG, Inc. · 2005
- Envelope gene-deficient Paramyxovirus vector4US 7,226,786 B2DNAVEC Research Inc. · 2007
- Virus envelope vector for gene transfer2US 7,279,333 B2AnGes MG, Inc. · 2007
- Virus envelope vector for gene transfer1US 7,803,621 B2AnGes MG, Inc. · 2010